Use of hydrogenated soya phospholipids as a diluent: preparation of sustained-release tablets of theophylline and sodium diclofenac.
Nishihata
T
T
Nakano
Y
Y
Yamazaki
M
M
D000818:Animals; D003692:Delayed-Action Preparations; D004008:Diclofenac / Q000008:administration & dosage / Q000032:analysis* / Q000493:pharmacokinetics; D004285:Dogs; D005079:Excipients; D008297:Male; D010743:Phospholipids / Q000032:analysis*; D013025:Glycine max / Q000032:analysis*; D013806:Theophylline / Q000008:administration & dosage / Q000032:analysis* / Q000493:pharmacokinetics
D003692:Delayed-Action Preparations; D005079:Excipients; D010743:Phospholipids; D004008:Diclofenac; D013806:Theophylline